Otros idiomas Baudax Bio, Inc.

Acciones

Mercado cerrado - OTC Markets Otros sitios de cotización 21:24:29 12/06/2024			Varia. Cinco días.	Varia. 1 de enero.
0,0068 ^USD	-19,05 %		-2,86 %	-69,09 %

22/02	Baudax Bio, Inc. se declaró en quiebra	CI
2023	Baudax Bio, Inc. informa de los resultados del tercer trimestre y los nueve meses finalizados el 30 de septiembre de 2023	CI

Baudax Bio, Inc. Filed for Bankruptcy	22/02
Baudax Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	20/11
Baudax Bio, Inc.(OTCPK:BXRX) dropped from S&P TMI Index	20/11
Baudax Bio, Inc.(OTCPK:BXRX) dropped from NASDAQ Composite Index	16/11
Baudax Bio : Change in Certifying Accountants - Form 8-K	25/10/23
Baudax Bio Announces Corporate Update	18/10/23
Baudax Bio, Inc. to Initiate TI-168 Clinical Development	18/10/23
Sector Update: Health Care Stocks Advancing in Late Afternoon Trading	06/10/23
Sector Update: Health Care Stocks Higher in Afternoon Trading	06/10/23
Baudax Bio Appoints Natalie McAndrew as Interim Finance Chief	06/10/23
Baudax Bio : Corporate Overview	06/10/23
Baudax Bio, Inc. Announces Board Changes	06/10/23
Baudax Bio, Inc. Announces Chief Financial Officer Changes	06/10/23
Wall Street Set to Open Higher; Personal Consumption Inflation Data Lower Than Expected	29/09/23
Top Premarket Decliners	29/09/23
Baudax Bio, Inc. Announces Orphan Drug Designation Granted by U.S. Fda for Ti-168 for the Treatment of Hemophilia A with Inhibitors	29/09/23
Sector Update: Health Care Stocks Rising in Late Afternoon Trading	28/09/23
Sector Update: Health Care	28/09/23
Top Midday Gainers	28/09/23
Baudax Bio Shares Double After Orphan Drug Designation for TI-168	28/09/23

No hay resultados para esta búsqueda